Gilead Sciences, Inc business logo
Medicine Questions
Report an Adverse Event
Investors
Contact
Global Operations
North America
  • Canada
  • Mexico
  • USA
South America
  • Argentina
  • Brazil
  • Colombia
Asia
  • China Mainland
  • Hong Kong
  • India
  • Japan
  • Korea
  • Singapore
  • Taiwan
Middle East
  • Israel
  • Saudi Arabia
  • Türkiye
  • United Arab Emirates
Africa
  • South Africa
Australia
  • Australia and New Zealand
Europe
  • Austria
  • Belgium and Luxembourg
  • Czech Republic & Slovakia
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Iceland
  • Ireland
  • Italy
  • Netherlands
  • Norway
  • Poland & The Baltics
  • Portugal
  • Romania
  • Russia
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom
Gilead Logo
  • Our Company
    About Us Leadership U.S. Public Policy Engagement Policies and Disclosures Supplier Information U.S. Locations
  • Our Purpose
    Partnerships and Community Corporate Giving Gilead Foundation Inclusion and Diversity Environmental, Social, Governance (ESG) Sustainability Advancing Global Health Health Equity Medication Access
  • Science & Medicine
    Our Therapeutic Areas Medicines Pipeline Research Clinical Trials Diversity in Clinical Trials
  • News and Press
    Events Stories Newsroom Company Statements Annual Reports
  • Careers
    Careers at Gilead Our Culture Meet Our Employees Inclusion and Diversity in Hiring Compensation, Benefits and Wellbeing Our Global Footprint Early Career Opportunities Postdoctoral Fellowships Hiring Events Talent Community Sign-up
  • Utility
    Privacy Statements Terms Of Use Social Media Guidelines Sitemap
BACK TO MAIN MENU Leadership Governance and Committees
BACK TO MAIN MENU U.S. Public Policy Engagement Political Contributions Archives
BACK TO MAIN MENU Policies and Disclosures Policies Disclosures
BACK TO MAIN MENU Supplier Information Supplier Enablement Resources Supplier Inclusion
BACK TO MAIN MENU Partnerships and Community COMPASS Initiative HepConnect HIV Age Positively Setting the P.A.C.E. Toward Health Equity for Black People Impacted by TNBC Toward Health Equity Oncology Grant RADIAN TRANScend Zeroing In: Ending the HIV Epidemic Zeroing In: Latin America & The Caribbean (LAC) Region
BACK TO MAIN MENU Corporate Giving What We Fund Funding Requests
BACK TO MAIN MENU Gilead Foundation Creating Possible Fund
BACK TO MAIN MENU Environmental, Social, Governance (ESG) Reporting U.N. Global Compact
BACK TO MAIN MENU Sustainability Our Business Is Sustainable Performance
BACK TO MAIN MENU Advancing Global Health COVID-19 HCV Elimination FOCUS
BACK TO MAIN MENU Medication Access U.S. Patient Access Global Access Authorized Distributors
BACK TO MAIN MENU Our Therapeutic Areas Virology Oncology Inflammation
BACK TO MAIN MENU Research Research Scholars Program Compassionate Use Community Based Participatory Research (CBPR) Investigator-Sponsored Research
BACK TO MAIN MENU Newsroom Press Releases Media Inquiries
BACK TO MAIN MENU Early Career Opportunities Internship Program
BACK TO MAIN MENU Privacy Statements Consumer Health Data Privacy Policy Cookie Statement Global Applicant Privacy Statement Healthcare Professional Privacy Notice - U.S. only Healthcare Professional Privacy Notice
BACK TO MAIN MENU
North America
  • Canada
  • Mexico
  • USA
South America
  • Argentina
  • Brazil
  • Colombia
Asia
  • China Mainland
  • Hong Kong
  • India
  • Japan
  • Korea
  • Singapore
  • Taiwan
Middle East
  • Israel
  • Saudi Arabia
  • Türkiye
  • United Arab Emirates
Africa
  • South Africa
Australia
  • Australia and New Zealand
Europe
  • Austria
  • Belgium and Luxembourg
  • Czech Republic & Slovakia
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Iceland
  • Ireland
  • Italy
  • Netherlands
  • Norway
  • Poland & The Baltics
  • Portugal
  • Romania
  • Russia
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom
BACK TO MAIN MENU

Contact

  • Request Medicines Information
  • Report an Adverse Event
  • Partnership Request
  • Report a Compliance Concern
  • Medicine Questions
  • Report an Adverse Event
  • Investors
  • Contact
  • Global Operations
Toggle Inner Dropdown
BACK TO MAIN MENU Google.com
  • Events
  • Stories
  • Newsroom
    • Press Releases
    • Media Inquiries
  • Company Statements
  • Annual Reports

Annual Reports

ESG

View our 2023 Environmental Social Governance Impact Report

Previous ESG Impact Reports

2022 Environmental Social Governance Impact Report

Previous Year in Review PDFs

Year in Review 2021

Year in Review 2021

Year in Review 2020

Year in Review 2020

Year in Review 2019

Year in Review 2019

Year in Review 2018

Year in Review 2018

Year in Review 2017

Year in Review 2016

Year in Review 2015

Year in Review 2014

Year in Review 2013

Year in Review 2012

Year in Review 2011

Gilead Sciences, Inc business logo

© 1996-2024 Gilead Sciences, Inc. All rights reserved.

AREAS OF INTEREST

  • Careers
  • Environmental, Social, Governance (ESG)
  • Medicines
  • Partnerships and Community
  • Pipeline
  • Stories@Gilead

INFORMATION

  • Contact Us
  • Investor Calls
  • Press Room
  • Report an Adverse Event
  • Report a Compliance Concern
  • Sitemap

LEGAL

  • Cookie Statement
  • Modern Slavery Act Statement
  • Privacy Statement
  • Consumer Health Data Privacy Policy
  • Public Policy Engagement
  • Social Media Guidelines
  • Terms of Use

FOLLOW US

  • Twitter
  • linkedin
  • Instagram
  • facebook
  • youtube

Headline

Intersititial body copy

Ok Cancel